Between 2022 and 2025, Panpharma successfully managed a large-scale project involving the construction of new buildings and the installation of state-of-the-art production equipment dedicated to the aseptic filling of sterile powders.
In June 2025, the development and qualification phases for both equipment and facilities were completed. Panpharma is now progressing with process validation for several antibiotic drugs, with the goal of making them available worldwide by the end of 2025.